by Dr. Joe Tatta
Pain Science Education discusses the treatment of persistent pain. Learn how to use the brain, body, mind, and behavior to reduce pain and improve physical and mental well-being. This podcast offers free training for physical therapists, healthcare professionals, and people with pain. Dr. Joe Tatta is a physical therapist, educator, author, and pain researcher. He is known for his contribution to integrative pain care and for championing the safe and effective treatment of chronic pain. With over 20 years of clinical expertise, Dr. Joe is dedicated to converting cutting-edge pain science into actionable therapeutic practices. An advocate for a biopsychosocial approach, Dr. Joe developed PRISM: Pain Recovery and Integrative Systems Model, a cognitive-behavioral approach that promotes resilience, growth, and recovery. Pain Science Education invites listeners to explore a wide array of subjects including pain education, pain neuroscience, physical therapy, physiotherapy, pain psychology, wellness, and continuing education. Episodes feature interviews with leading experts, offering a deep dive into the pivotal topics shaping the field of pain management. The insights shared here aim to propel the practice of physical therapy to the forefront of primary pain management. Dr. Joe Tatta is committed to guiding therapists and healthcare providers through the complexities of pain, equipping them with the knowledge to deliver non-pharmacologic and non-invasive approaches to chronic pain. With Dr. Joe's guidance, listeners will uncover the potential of physical therapists as pivotal figures in pain management, understand the importance of health behavior change, and learn how to use integrative and lifestyle medicine in practice. Join the Pain Science Education podcast to transform your clinical approach, enrich your professional toolkit, and participate in the revolution of pain management. Each episode promises to take you one step closer to learning about pain, becoming a leader in delivering exceptional, innovative care to those suffering with pain, and ultimately improving lives across the globe.
Language
🇺🇲
Publishing Since
5/6/2016
Email Addresses
1 available
Phone Numbers
0 available
March 18, 2025
<p>In this episode, Joe Tatta, PT, DPT, speaks with physiotherapist and researcher Tash Pocovi, PhD about her groundbreaking study in the Lancet on the e<span style="font-size: 12pt;">ffectiveness and cost-effectiveness of an individualized, progressive walking and education intervention for the prevention of low back pain recurrence.</span></p> <div data-type="rootblock" data-pm-slice= "2 2 ["aiblock",{"prompt":"","preview":false,"block":{"id":"blk_01JPN9AH7WVHWZTSJKNF2F81MM","status":"succeeded","type":"prompt","selected_variation":0,"variations":["# Podcast Episode Summary\n\nIn this week's episode, I had the pleasure of speaking with Dr. Tash Pocovi about her groundbreaking research on the prevention of low back pain. Dr. Pocovi recently published a randomized control trial in the June 2024 issue of The Lancet, focusing on the effectiveness and cost-effectiveness of a progressive walking program combined with educational intervention for preventing low back pain in an Australian population.\n\nDr. Pocovi explained that the motivation behind the study was the high recurrence rate of low back pain, with about 70% of individuals experiencing a new episode within 12 months of recovery. The research aimed to explore simple, accessible, and low-cost interventions, leading them to investigate walking as a preventive measure.\n\nThe trial, known as the Walk Back Trial, involved 24 physiotherapists across Australia who delivered an individualized and progressive walking program along with education. The participants, who were mostly sedentary, were given walking prescriptions tailored to their current activity levels, age, BMI, and comorbidities. The goal was to gradually increase their walking to 30 minutes most days of the week over six months.\n\nThe results were promising, showing a 28% relative risk reduction in low back pain recurrences and a 43% reduction in care-seeking episodes. This has significant implications for both individual health and healthcare system burdens, highlighting the potential of simple interventions like walking combined with education.\n\nDr. Pocovi also discussed the cost-effectiveness of the intervention, noting that it was highly likely to be cost-effective based on willingness-to-pay thresholds. The biggest savings were seen in reduced work absenteeism.\n\nInterestingly, the trial was conducted during the COVID-19 pandemic, which necessitated a shift to telehealth delivery. This change allowed for broader recruitment, including participants from rural and remote areas, and was well-received by both participants and clinicians.\n\nLooking ahead, Dr. Pocovi aims to delve deeper into the data to identify which participant characteristics influence the effectiveness of the intervention and explore ways to implement this approach in clinical care.\n\nFor more details, you can follow Dr. Pocovi on Twitter and access the full paper in The Lancet. Don't forget to share this episode with your colleagues and friends who are interested in the prevention and treatment of low back pain. See you next week!"],"configuration":{"id":"blk_cfg_01HJ2RSYX80BRQFSPJZA6R9QT1","type":"prompt","name":"Summary","description":null,"markdown_value":null,"prompt_value":"Write a summary for this podcast episode from the perspective of the podcast host","archived_at":null,"saved":true,"timestamp_configuration":null,"quote_configuration":null},"prosemirror":[{"type":"rootblock","content":[{"type":"heading","attrs":{"level":1},"content":[{"type":"text","text":"Podcast Episode Summary"}]},{"type":"paragraph","content":[{"type":"text","text":"In this week's episode, I had the pleasure of speaking with Dr. Tash Pocovi about her groundbreaking research on the prevention of low back pain. Dr. Pocovi recently published a randomized control trial in the June 2024 issue of The Lancet, focusing on the effectiveness and cost-effectiveness of a progressive walking program combined with educational intervention for preventing low back pain in an Australian population."}]},{"type":"paragraph","content":[{"type":"text","text":"Dr. Pocovi explained that the motivation behind the study was the high recurrence rate of low back pain, with about 70% of individuals experiencing a new episode within 12 months of recovery. The research aimed to explore simple, accessible, and low-cost interventions, leading them to investigate walking as a preventive measure."}]},{"type":"paragraph","content":[{"type":"text","text":"The trial, known as the Walk Back Trial, involved 24 physiotherapists across Australia who delivered an individualized and progressive walking program along with education. The participants, who were mostly sedentary, were given walking prescriptions tailored to their current activity levels, age, BMI, and comorbidities. The goal was to gradually increase their walking to 30 minutes most days of the week over six months."}]},{"type":"paragraph","content":[{"type":"text","text":"The results were promising, showing a 28% relative risk reduction in low back pain recurrences and a 43% reduction in care-seeking episodes. This has significant implications for both individual health and healthcare system burdens, highlighting the potential of simple interventions like walking combined with education."}]},{"type":"paragraph","content":[{"type":"text","text":"Dr. Pocovi also discussed the cost-effectiveness of the intervention, noting that it was highly likely to be cost-effective based on willingness-to-pay thresholds. The biggest savings were seen in reduced work absenteeism."}]},{"type":"paragraph","content":[{"type":"text","text":"Interestingly, the trial was conducted during the COVID-19 pandemic, which necessitated a shift to telehealth delivery. This change allowed for broader recruitment, including participants from rural and remote areas, and was well-received by both participants and clinicians."}]},{"type":"paragraph","content":[{"type":"text","text":"Looking ahead, Dr. Pocovi aims to delve deeper into the data to identify which participant characteristics influence the effectiveness of the intervention and explore ways to implement this approach in clinical care."}]},{"type":"paragraph","content":[{"type":"text","text":"For more details, you can follow Dr. Pocovi on Twitter and access the full paper in The Lancet. Don't forget to share this episode with your colleagues and friends who are interested in the prevention and treatment of low back pain. See you next week!"}]}]}],"previous_block":null,"next_block":null,"error_code":null,"feedback":null},"template":{"type":"block_configuration","block_configuration_id":"blk_cfg_01HJ2RSYX80BRQFSPJZA6R9QT1","prompt_value":"Write a summary for this podcast episode from the perspective of the podcast host","name":"Summary"}}]"> <p>The trial, known as the Walk Back Trial, involved 24 physiotherapists across Australia who delivered an individualized and progressive walking program along with education. The participants, who were mostly sedentary, were given walking prescriptions tailored to their current activity levels, age, BMI, and comorbidities. The goal was to gradually increase their walking to 30 minutes most days of the week over six months.</p> <p>The results were promising, showing a relative risk reduction in low back pain recurrences and a reduction in care-seeking episodes. This has significant implications for both individual health and healthcare system burdens, highlighting the potential of simple interventions like walking combined with education.</p> <p>Dr. Pocovi also discussed the cost-effectiveness of the intervention, noting that it was highly likely to be cost-effective based on willingness-to-pay thresholds. The biggest savings were seen in reduced work absenteeism.</p> </div> <p>For more information, please visit <a href= "https://integrativepainscienceinstitute.com/">integrativepainscienceinstitute.com </a></p> <p>For CEU courses, please visit <a href= "https://integrativepainscienceinstitute.com/course/">integrativepainscienceinstitute.com/course/</a></p> <p>Love the show? Please subscribe, rate, and review.</p> <p>Thank you for listening, </p> <p>Joe Tatta, PT, DPT <br /> CEO, Integrative Pain Science Institute</p>
February 22, 2025
<p>In this special webinar episode, Joe Tatta, PT, DPT, and Rose Pignataro, PT, DPT, PhD, FAPTA, a leading researcher and physical therapist specializing in health behavior change, discuss how healthy eating can relieve chronic pain. They also discuss strategies to help patients adhere to and sustain nutritional changes.</p> <p>For more information, please visit <a href= "https://integrativepainscienceinstitute.com/">integrativepainscienceinstitute.com</a></p> <p>For CEU courses, please visit <a href= "integrativepainscienceinstitute.com/course/">https://integrativepainscienceinstitute.com/course/</a></p> <p>Love the show? Please subscribe, rate, and review.</p> <p>Thank you for listening.</p> <p>Joe Tatta, PT, DPT<br /> CEO Integrative Pain Science Institute</p>
February 10, 2025
<p>In this episode, Joe Tatta, PT, DPT speaks with Anthony Delitto, PT, PhD, FAPTA a leading researcher in musculoskeletal pain, with over 100 peer-reviewed publications and a career dedicated to improving pain care. Dr. Delitto led the groundbreaking TARGET Trial, a $13-million PCORI-funded study investigating how early intervention with physical therapy—specifically, psychologically-informed physical therapy—can prevent acute low back pain from becoming chronic.</p> <p>In this episode, we dive into the findings of the TARGET Trial, how primary care providers can be trained to recognize risk factors for persistent pain, and why timely referral to physical therapy matters. We also discuss the critical role of physical therapists as primary care providers, the broader impact of poorly managed pain—including the overuse of opioids, unnecessary imaging, and low-value care—and what all of this means for patients, healthcare systems, and employers.</p> <p>For more information, please visit integrativepainscienceinstitute.com </p> <p>For CEU courses, please visit https://integrativepainscienceinstitute.com/course/</p> <p>Love the show? Please subscribe, rate, and review.</p> <p>Thank you for listening, </p> <p>Joe Tatta, PT, DPT <br /> CEO Integrative Pain Science Institute</p>
Curable: the program for chronic pain recovery through mindbody medicine
Nicole Sachs, LCSW
Untangle
Vox Media Podcast Network
Oprah
Pushkin Industries
Dr Rangan Chatterjee: GP & Author
Tami Simon
Mel Robbins
10% Happier
Esther Perel Global Media
Glennon Doyle and Audacy
Dr. Jen Fraboni & Dr. Dom Fraboni
Amanda Armstrong
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.